PBMD

Prima BioMed Ltd Press Releases

$1.2201
*  
0.0499
3.93%
Get PBMD Alerts
*Delayed - data as of Jul. 30, 2015  -  Find a broker to begin trading PBMD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PBMD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Active Equities to Watch in the Biotechnology Industry -- Prima Biomed, Oncothyreon, Opko Health, ImmunoCellular Therapeutics, and Adaptimmune Therapeutics
7/15/2015 9:00:00 AM - PR Newswire
▼-13.47 % Price Change since this news event. The Volume Ratio is 2.59.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Prima BioMed Receives Positive Scientific Advice From the European Medicines Agency for Its Lead Product, IMP321
7/7/2015 7:00:00 AM - Market Wire
▼-30.68 % Price Change since this news event. The Volume Ratio is 24.66.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed Receives a Research Tax Credit Cash Rebate in France
6/11/2015 7:00:00 AM - Market Wire
▼-42.99 % Price Change since this news event. The Volume Ratio is 0.44.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed to Maintain NASDAQ Listing
6/4/2015 7:00:00 AM - Market Wire
▼-41.90 % Price Change since this news event. The Volume Ratio is 0.37.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed Announces New IP for Its Lead IMP321 Development Program
5/29/2015 7:00:00 AM - Market Wire
▼-50.80 % Price Change since this news event. The Volume Ratio is 0.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed to Commercialise CVac's Database Management Platform With Database Integrations Inc. (DBI)
5/27/2015 10:24:00 AM - Market Wire
▼-56.11 % Price Change since this news event. The Volume Ratio is 0.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CVac Shows Clear Trend for Overall Survival Benefit in Second Remission Ovarian Cancer in Phase II Study
5/26/2015 7:50:00 AM - Market Wire
▼-63.03 % Price Change since this news event. The Volume Ratio is 1.22.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Correction Continues after Big Move - BrokerBank Securities, Inc.
5/21/2015 3:00:00 PM - PR Newswire
▼-60.64 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CVac Shows Clear Trend for Overall Survival Benefit in Second Remission Ovarian Cancer in Phase II Study
5/19/2015 10:19:00 AM - Market Wire
▲67.14 % Price Change since this news event. The Volume Ratio is 247.47.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed Announces A$15 Million Investment From US Healthcare Investor Ridgeback
5/14/2015 6:45:00 AM - Market Wire
▲110.36 % Price Change since this news event. The Volume Ratio is 1.14.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Prima BioMed Announces Japanese Collaboration
5/11/2015 7:45:00 AM - Market Wire